Effect of Adding Losartan to Bevacizumab for Treating Diabetic Macular Edema

Table 2

Comparison of BCVA results of two groups after first, third, and sixth months follow-up.

Best-corrected visual acuity (BCVA)#	Case group (n = 33)	Control group	value
Before intervention	0.47 ± 0.32	0.45 ± 0.26	0.86
One month after intervention	0.40 ± 0.31	0.37 ± 0.22	0.71
Three months after intervention	0.33 ± 0.26	0.36 ± 0.24	0.66
Six months after intervention	0.27 ± 0.26	0.25 ± 0.23	0.68

T-test. Based on Log MAR